title: CYP2C19 and ABCB1 genes and individualized treatment with clopidogrel.
authors.forename: Bas J M
authors.initials: BJ
authors.lastname: Peters
authors.forename: Ankie M
authors.initials: AM
authors.lastname: Harmsze
authors.forename: Jurriën M
authors.initials: JM
authors.lastname: ten Berg
authors.forename: Anke-Hilse
authors.initials: AH
authors.lastname: Maitland-van der Zee
authors.forename: Mathieu M
authors.initials: MM
authors.lastname: Tjoeng
authors.forename: Anthonius
authors.initials: A
authors.lastname: de Boer
authors.forename: Vera H M
authors.initials: VH
authors.lastname: Deneer
mesh_terms: D018435:ATP Binding Cassette Transporter, Subfamily B; D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1 / Q000235:genetics*; D054058:Acute Coronary Syndrome / Q000188:drug therapy*; D001189:Aryl Hydrocarbon Hydroxylases / Q000235:genetics*; D000077144:Clopidogrel; D065731:Cytochrome P-450 CYP2C19; D014644:Genetic Variation / Q000187:drug effects; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D057285:Precision Medicine; D013988:Ticlopidine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: C513055:ABCB1 protein, human; D018435:ATP Binding Cassette Transporter, Subfamily B; D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D010975:Platelet Aggregation Inhibitors; D000077144:Clopidogrel; D001189:Aryl Hydrocarbon Hydroxylases; C045793:CYP2C19 protein, human; D065731:Cytochrome P-450 CYP2C19; D013988:Ticlopidine